What are the differences between dexamethasone, betamethasone, and prednisolone, and for which diseases (including off‑label and FDA‑approved indications) is each drug preferred?

Dexamethasone vs Betamethasone vs Prednisolone: Key Differences and Disease-Specific Uses

For most rheumatic and inflammatory conditions requiring chronic oral corticosteroid therapy, prednisolone is the preferred agent due to superior safety profile with less adrenal suppression at equipotent doses, while dexamethasone is specifically indicated for cerebral edema and certain acute conditions, and betamethasone is reserved primarily for antenatal fetal lung maturation.

Pharmacologic Differences

Potency and Duration

• Dexamethasone: Most potent (25-30x hydrocortisone), longest half-life (36-72 hours), no mineralocorticoid activity
• Betamethasone: Similar potency to dexamethasone (25x hydrocortisone), long-acting, minimal mineralocorticoid activity
• Prednisolone: Intermediate potency (4x hydrocortisone), intermediate duration (12-36 hours), mild mineralocorticoid activity

Placental Transfer

A critical distinguishing feature: Dexamethasone and betamethasone cross the placenta extensively (85-90% reaches fetus), while prednisolone is largely metabolized by placenta with only 10% reaching fetal circulation 1, 2, 3.

Disease-Specific Recommendations

Pregnancy-Related Indications

For fetal lung maturation (antenatal corticosteroids):

• Betamethasone is preferred over dexamethasone for preventing neonatal respiratory distress syndrome 4
• Standard regimen: Betamethasone 12 mg IM every 24 hours x 2 doses
• Recent evidence suggests both drugs may be equally effective, but betamethasone has more established safety data 4, 5
• Important caveat: Emerging data suggests current doses may be excessive; lower-dose regimens are under investigation to minimize potential long-term neurodevelopmental effects while maintaining efficacy 5

For maternal rheumatic disease during pregnancy:

• Prednisolone is the drug of choice because minimal placental transfer protects the fetus from corticosteroid exposure 1
• Methylprednisolone is an acceptable alternative
• Avoid dexamethasone for maternal indications unless fetal treatment is specifically intended

Rheumatic Diseases (Chronic Therapy)

For rheumatoid arthritis, polymyalgia rheumatica, and other chronic inflammatory conditions:

• Prednisolone is strongly preferred over betamethasone for chronic oral dosing 6
• At equipotent doses (prednisolone 8 mg vs betamethasone 1 mg daily), prednisolone causes significantly less adrenal suppression while maintaining equivalent clinical efficacy 6
• Patient preference also favors prednisolone (13 vs 7 in one study) 6
• Typical starting dose: 5-20 mg daily, tapered to lowest effective dose 1

For acute rheumatic exacerbations:

• Short-term use of any corticosteroid is acceptable 2
• Prednisolone remains preferred for ease of tapering and less HPA axis suppression

Neurologic Conditions

For cerebral edema (primary or metastatic brain tumor, head injury, craniotomy):

• Dexamethasone is the drug of choice 2
• High potency and minimal mineralocorticoid activity make it ideal for reducing intracranial pressure
• Not a substitute for neurosurgical evaluation

For chronic inflammatory demyelinating polyradiculoneuropathy (CIDP):

• High-dose monthly oral dexamethasone (e.g., 40 mg daily x 4 days monthly) is equally effective to daily prednisolone but with fewer side effects 7
• Significantly less moon facies and insomnia with monthly dexamethasone regimen 7
• Daily prednisolone remains an option but expect more cushingoid features

Respiratory Conditions

For pediatric acute asthma exacerbations:

• Dexamethasone is increasingly preferred over prednisone, particularly in pediatric emergency medicine 8
• Advantages: Single or 2-dose regimen (vs 5-day prednisone course), improved compliance, better taste, lower cost
• Typical dose: 0.6 mg/kg (max 10 mg) as single dose or daily x 2 days 8
• Important: Pediatric pulmonology and allergy specialists still predominantly use prednisone (89-93%), but evidence supports dexamethasone 8

For adult asthma and COPD exacerbations:

• Prednisolone 40-50 mg daily x 5 days remains standard
• Dexamethasone alternatives are emerging but less established in adults

COVID-19 (Severe/Critical Disease)

For hospitalized patients requiring supplemental oxygen:

• Dexamethasone 6 mg daily (oral or IV) x 10 days is the evidence-based standard 9, 10
• Multiple recent studies confirm dexamethasone superiority over methylprednisolone for severe COVID-19:
  • Lower mortality (3.2% vs 13.7%) 10
  • Shorter hospital stays 9, 10
  • Less need for mechanical ventilation 10
• Do not substitute methylprednisolone despite theoretical equipotency; clinical outcomes are inferior 9, 10

Epidural Steroid Injections

For lumbar transforaminal epidural injections:

• Dexamethasone (nonparticulate) is strongly preferred over betamethasone or methylprednisolone (particulate steroids) 11
• Particulate steroids carry risk of catastrophic spinal cord infarction if inadvertently injected intravascularly
• Clinical outcomes favor nonparticulate steroids: 87.5% of dexamethasone patients required zero repeat injections within 12 months vs only 71.4% with particulate steroids 11
• Safety profile is superior with no embolic complications

Other FDA-Approved Indications

Conditions where dexamethasone is specifically indicated 2:

• Diagnostic testing of adrenocortical hyperfunction
• Tuberculous meningitis with subarachnoid block (with antituberculous therapy)
• Cerebral edema (as noted above)
• Certain hematologic malignancies (leukemias, lymphomas)

Conditions where prednisolone/prednisone is preferred:

• Most rheumatic diseases requiring chronic therapy 1, 6
• Inflammatory bowel disease (ulcerative colitis, Crohn's disease) 2
• Nephrotic syndrome 2
• Adrenal insufficiency (though hydrocortisone is first-line)

Critical Clinical Pitfalls

Adrenal Suppression

• Betamethasone and dexamethasone cause more profound HPA axis suppression than prednisolone at equipotent doses 6
• For chronic therapy, this favors prednisolone
• All patients on corticosteroids >3 weeks require stress-dose coverage for surgery: hydrocortisone 100 mg IV before anesthesia, then every 8 hours x 4 doses 1

Pregnancy Considerations

• Never use dexamethasone or betamethasone for maternal conditions unless fetal treatment is intended 1
• Prednisolone/methylprednisolone are FDA Category B in pregnancy 1
• Breastfeeding is safe with low-dose corticosteroids; avoid feeding within 4 hours of dose to minimize infant exposure 1

Pediatric Growth

• All corticosteroids impair linear growth in children
• Monitor growth regularly and consider growth hormone replacement if impairment occurs 1
• This applies equally to all three agents

Infection Risk

• Corticosteroids increase infection susceptibility regardless of agent
• Screen for latent tuberculosis before initiating therapy
• Consider prophylaxis for Pneumocystis jirovecii if prolonged high-dose therapy anticipated

Practical Dosing Equivalencies

When converting between agents:

• Prednisolone 5 mg = Dexamethasone 0.75 mg = Betamethasone 0.6 mg
• However, do not assume clinical equivalence—as demonstrated, outcomes differ even at equipotent doses depending on indication 6, 9, 10, 11